1. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4.
2. Morton RA. Ubiquinones, plastoquinones and vitamins K. Biol Rev Camb Philos Soc 1971;46:47–96.
3. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344:1372–3 [letter].
4. Combs AB, Porter TH, Folkers K. Anticoagulant activity of a naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q10-enzyme systems. Res Commun Chem Pathol Pharmacol 1976;13:109–14.
5. Landbo C, Almdal TP. Interaction between warfarin and coenzyme Q10. Ugeskr Laeger 1998;160:3226–7 [in Danish].
6. Pinto JT. The pharmacokinetic and pharmacodynamic interactions of foods and drugs. Topics in Clinical Nutrition 1991;6:14–33.
7. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997;17:342–56.
8. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4.
9. Rosenthal G. Interaction of ascorbic acid and warfarin. JAMA 1971;215:1671.
10. Schrogie JJ. Coagulopathy and fat soluble vitamins. JAMA 1975;232:19 [letter].
11. Corrigan J, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA 1974;230:1300–1.
12. Corrigan JJ Jr, Ulfers LL. Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am J Clin Nutr 1981;34:1701–5.
13. Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 1996;77:545–6.
14. Taylor CT, Chester EA, Byrd DC, Stephens MA.
Vitamin K to reverse excessive anticoagulation: A review of the literature. Pharmacotherapy 1999;19:1415–25.
15. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and applications. J Am Diet Assoc 1995;95:580–4.
16. Kodaka K, Ujiie T, Ueno T, Saito M. Contents of vitamin K1 and chlorophyll in green vegetables. J Jpn Soc Nutr Food Sci 1986;39:124–6.
17. Booth SL, Centurelli MA. Vitamin K: a practical guide to the dietary management of patients on warfarin. Nutr Rev 1999;57:288–96 [review].
18. Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 1997;125:959–62.
19. Reese AM, Farnett LE, Lyons RM, et al. Low-dose vitamin K to augment anticoagulation control. Pharmacotherapy 2005;25:1746–51.
20. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007;109:2419–23.
21. Rombouts EK, Rosendaal FR, Van Der Meer FJM. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 2007;5:2043–8.
22. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692–3.
23. Lee SH, Ahn YM, Ahn SY, et al. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008;14:715–21.
24. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80.
25. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175–80.
26. Yuan CS, Wei G, Dey L,
et al. Brief communication: American ginseng reduces warfarin's effect in
healthy patients: a randomized, controlled Trial. Ann Intern Med
2004;141:23–7.
27. No authors listed. Possible interaction between warfarin and cranberry juice. Curr Prob Pharmacovigilance 2003;29:8.
28. Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin potentiation by
“danshen.”J Intern Med 1997;241:337–9.
29. Tam LS, Chan TY, Leung WK, Critchley JA. Warfarin interactions with Chinese traditional medicines: Danshen and methyl salicylate medicated oil. Aust NZ J Med 1995;25:258.
30. Chan TY. Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients
receiving warfarin. Int J Clin Pharmacol Ther 1998;36:403–5.
31. Izzat MB, Yim AP, El-Zufari MH. A taste of Chinese medicine! Ann Thorac Surg 1998;66:941–2.
32. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug Saf 1997;17:342–56.
33. Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Phamacotherapy 1999;19:870–6.
34. Heptinstall S, Groenewegen WA, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol 1987;39:459–65.
35. Heptinstall S, Groenewegen WA, Spangenberg P, Losche W. Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch 1988;115:447–9.
36. Loesche W, Mazurov AV, Voyno-Yasenetskaya TA, et al. Feverfew—an antithrombotic drug? Folia Haematol Int Mag Klin Morphol Blutforsch 1988;115:181–4.
37. Rose KD, Croissant PD, Parliment CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report. Neurosurgery 1990;26:880–2.
38. Gadkari JV, Joshi VD. Effect of ingestion of raw garlic on serum cholesterol level, clotting time and fibrinolytic activity in normal subjects. J Postgrad Med 1991;37:128–31.
39. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconst Surg 1995;95:213.
40. Sunter WH. Warfarin and garlic. Pharm J 1991;246:722 [letter].
41. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press, 1996, 135–7.
42. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136–9.
43. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108.
44. Rowin J, Lewis SL. Spontaneous bilateral subdural hematoma with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775–6.
45. Mathews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998;50:1934.
46. Gilbert GJ. Ginkgo biloba. Lancet 1997;1137 [letter].
47. Brandin H, Myrberg O, Rundlof T, et al. Adverse effects by artificial grapefruit seed extract products in patients on warfarin therapy. Eur J Clin Pharmacol 2007;63:565–70.
48. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999;33:426–8.
49. Miller LG, Murray WJ, eds. Herbal Medicinals: A Clinician’s Guide. New York: Pharmaceutical Products Press, 1999, 313–5.
50.
Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium
barbarum L. Ann Pharmacother 2001;35:1199–201.
51. Hanselin MR. Vande Griend JP, Linnebur SA. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother 2010;44:223–4.
52. Tatro D, ed. Anticoagulants-quinine derivatives. In Drug Interaction Facts. St. Louis, MO: Facts and Comparisons, Jul 1993.
53. Wong ALN, Chan TYK. Interaction between warfarin and the
herbal product quilinggao. Ann Pharmacother 2003;37:836–8.
54. Brinker F. Herb Contraindications and Drug Interactions. Sandy, OR: Eclectic Medical Publications, 1998,166–9.
55. Mauer A, Johne A, Bauer S, et al. Interaction of St. John’s wort extract with phenprocoumon [abstract]. Eur J Clin Pharmacol 1999;55:A22.
56. Safety of St. John’s wort (Hypericum perforatum) [letters, various authors]. Lancet 2000;355:575–7.
57. Nebel A, Schneider BJ, Baker RK, Kroll DJ. Potential metabolic interaction between St. John’s wort and theophylline [letter]. Ann Pharmacother 1999;33:502.
58. Mai I, Schmider J, et al. Unpublished results, May 1999. Reported in:
Johne A, Brockmöller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an
herbal extract from St. John’s wort (Hypericum perforatum). Clin Pharmacol Ther
1999;66:338–45.
59. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 282.
60. Havrda DE, Mai T, Chonlahan J. Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption. Pharmacotherapy 2005;25:303–7.
61. Harris JE. Interaction of dietary factors with oral anticoagulants: Review and application. J Am Diet Assoc 1995;95:580–4.
62. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 293.
63. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5.
64. Holt GA. Food & Drug Interactions. Chicago, Precept Press, 1998, 284–5.
65. Cambria-Kiely JA. Effect of soy milk on warfarin efficacy. Ann Pharmacother 2002;36:1893–6.
66. Monterrey-Rodriguez J. Interaction
between warfarin and mango fruit. Ann Pharmacother 2002;36:940–1.
67. Beatty SJ, Mehta BH, Rodis JL. Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. Ann Pharmacother 2005;39:744–7.
68. Food additives for direct addition to food for human consumption; olestra; final rule. 21 Federal Register 1996:3118–73.
69. Harrell CC, Kline SS. Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin. JAMA 1999;282:1133–4.